• Loading stock data...
Est. 2004

Thursday 03/7/2019

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More


  • 4:44 PM

    Jan 14, 2016, MSLP,  OTC Disclosure & News Service – MusclePharm Corporation (OTCQB: MSLP) (“MusclePharm” or the “Company”), a scientifically-driven, performance lifestyle sports nutrition company, today announced the completion of a financing agreement with Prestige Capital Corporation (“Prestige Capital”) in the initial amount of $10 million. The financing agreement is a major step towards strengthening the Company’s financial position. The agreement with Prestige Capital allows the Company to use its receivables to finance up to a total of $10 million. The Company

    Read more
  • 2:59 PM

    http://www.publicwire.comNuvilex Retains TD2 to Conduct Preclinical and Clinical Studies SILVER SPRING, Apr 01, 2014 (GLOBE NEWSWIRE via COMTEX) — Nuvilex, Inc. (OTCQB:NVLX), a clinical-stage international biotechnology company providing cell and gene therapy solutions for the treatment of diseases, announced today that it has signed a Master Services Agreement with Translational Drug Development (TD2) pursuant to which TD2 will conduct preclinical and clinical studies in support of the development of Nuvilex’s pancreatic cancer and other treatments utilizing Cell-in-a-Boxtechnology. “The Nuvilex team

    Read more
Public Wire Banner